Mike Theis, Healthesystems’ AVP of Product Analytics & Business Strategy, discusses the evolving role of analytics in workers’ comp managed care programs
The GLP-1 receptor agonist has been considered in shortage since 2022, but the FDA confirmed with manufacturers that presented and projected demand can now be met.